|
1
|
WHO COVID-19 Situation report 51. 11 March
2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10,
Accessed June 15, 2020.
|
|
2
|
V'kovski P, Kratzel A, Steiner S, Stalder
H and Thiel V: Coronavirus biology and replication: Implications
for SARS-CoV-2. Nat Rev Microbiol. 19:155–170. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S
and Ma K: A systematic review of asymptomatic infections with
COVID-19. J Microbiol Immunol Infect. 54:12–16. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Singh D and Yi SV: On the origin and
evolution of SARS-CoV-2. Exp Mol Med. 53:537–547. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Izda V, Jeffries MA and Sawalha AH:
COVID-19: A review of therapeutic strategies and vaccine
candidates. Clin Immunol. 222(108634)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ita K: Coronavirus disease (COVID-19):
Current status and prospects for drug and vaccine development. Arch
Med Res. 52:15–24. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cappanera S, Palumbo M, Kwan SH, Priante
G, Martella LA, Saraca LM, Sicari F, Vernelli C, Di Giuli C,
Andreani P, et al: When does the cytokine storm begin in COVID-19
patients? A quick score to recognize it. J Clin Med.
10(297)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Asakura H and Ogawa H: COVID-19-associated
coagulopathy and disseminated intravascular coagulation. Int J
Hematol. 113:45–57. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
O'Shea JJ, Gadina M and Siegel R:
Cytokines and cytokine receptors. In: Principles of Immune
Response. Elsevier, Amsterdam, pp108-135, 2013.
|
|
10
|
Shah S, Shah K, Patel SB, Patel FS, Osman
M, Velagapudi P, Turagam MK, Lakkireddy D and Garg J: Elevated
D-dimer levels are associated with increased risk of mortality in
Coronavirus disease 2019: A systematic review and meta-analysis.
Cardiol Rev. 28:295–302. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yokota S, Itoh Y, Morio T, Sumitomo N,
Daimaru K and Minota S: Macrophage activation syndrome in patients
with systemic juvenile idiopathic arthritis under treatment with
tocilizumab. J Rheumatol. 42:712–722. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Huang LM, Hu Q, Huang X, Qian Y and Lai
XH: Preconditioning rats with three lipid emulsions prior to acute
lung injury affects cytokine production and cell apoptosis in the
lung and liver. Lipids Health Dis. 19(19)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li Y, Zhou W, Yang L and You R:
Physiological and pathological regulation of ACE2, the SARS-CoV-2
receptor. Pharmacol Res. 157(104833)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yan Y, Chang L and Wang L: Laboratory
testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current
status, challenges, and countermeasures. Rev Med Virol.
30(e2106)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liya G, Yuguang W, Jian L, Huaiping Y, Xue
H, Jianwei H, Jiaju M, Youran L, Chen M and Yiqing J: Studies on
viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV,
and MERS-CoV: A literature review. APMIS. 128:423–432.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gabutti G, d'Anchera E, Sandri F, Savio M
and Stefanati A: Coronavirus: Update related to the current
outbreak of COVID-19. Infect Dis Ther. 9:1–13. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yang W, Sirajuddin A, Zhang X, Zhang X,
Liu G, Teng Z, Zhao S and Lu M: The role of imaging in 2019 novel
coronavirus pneumonia (COVID-19). Eur Radiol. 30:4874–4882.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lamers MM, Beumer J, van der Vaart J,
Knoops K, Puschhof J, Breugem TI, Ravelli RB, Paul van Schayck JP,
Mykytyn AZ, Duimel HQ, et al: SARS-CoV-2 productively infects human
gut enterocytes. Science. 369:50–54. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
WHO COVID-19 Situation report 37. 26
February 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200226-sitrep-37-covid-19.pdf?sfvrsn=2146841e_2,
Accessed June 15, 2020.
|
|
20
|
WHO COVID-19 Situation report 75. 4 April
2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200404-sitrep-75-covid-19.pdf?sfvrsn=99251b2b_4,
Accessed June 15, 2020.
|
|
21
|
WHO COVID-19 Situation report 87. 16 April
2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200416-sitrep-87-covid-19.pdf?sfvrsn=9523115a_2,
Accessed June 15, 2020.
|
|
22
|
Mohamadian M, Chiti H, Shoghli A, Biglari
S, Parsamanesh N and Esmaeilzadeh A: COVID-19: Virology, biology
and novel laboratory diagnosis. J Gene Med.
23(e3303)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chung JY, Thone MN and Kwon YJ: COVID-19
vaccines: The status and perspectives in delivery points of view.
Adv Drug Deliv Rev. 170:1–25. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yesudhas D, Srivastava A and Gromiha MM:
COVID-19 outbreak: History, mechanism, transmission, structural
studies and therapeutics. Infection. 49:199–213. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
WHO COVID-19 Situation report 102. 1 May
2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200501-covid-19-sitrep.pdf?sfvrsn=742f4a18_4,
Accessed June 15, 2020.
|
|
26
|
WHO COVID-19 Situation report 116. 15 May
2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200515-covid-19-sitrep-116.pdf?sfvrsn=8dd60956_2,
Accessed June 15, 2020.
|
|
27
|
WHO Multisystem inflammatory syndrome in
children and adolescents with COVID-19. 15. May 2020. Available
from: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19,
Accessed June 15, 2020.
|
|
28
|
WHO COVID-19 Situation report 133. 1 June
2020. Avalable from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200601-covid-19-sitrep-133.pdf?sfvrsn=9a56f2ac_4,
Accessed June 15, 2020.
|
|
29
|
Kaur N, Singh R, Dar Z, Bijarnia RK,
Dhingra N and Kaur T: Genetic comparison among various coronavirus
strains for the identification of potential vaccine targets of
SARS-CoV2. Infect Genet Evol. 89(104490)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lednicky JA, Tagliamonte MS, White SK,
Elbadry MA, Alam MM, Stephenson CJ, Bonny TS, Loeb JC, Telisma T,
Chavannes S, et al: Emergence of porcine delta-coronavirus
pathogenic infections among children in Haiti through independent
zoonoses and convergent evolution. medRxiv: Mar 25, 2021 (Epub
ahead of print). doi: 10.1101/2021.03.19.21253391.
|
|
31
|
Callaway E: Delta coronavirus variant:
Scientists brace for impact. Nature. 595:17–18. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Torjesen I: Covid-19: Delta variant is now
UK's most dominant strain and spreading through schools. BMJ.
373(n1445)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tufan A, Avanoğlu Güler A and
Matucci-Cerinic M: COVID-19, immune system response,
hyperinflammation and repurposing antirheumatic drugs. Turk J Med
Sci. 50:620–632. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang Y, Geng X, Tan Y, Li Q, Xu C, Xu J,
Hao L, Zeng Z, Luo X, Liu F and Wang H: New understanding of the
damage of SARS-CoV-2 infection outside the respiratory system,
Biomed. Pharmacother. 127(110195)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Salian VS, Wright JA, Vedell PT, Nair S,
Li C, Kandimalla M, Tang X, Carmona Porquera EM, Kalari KR and
Kandimalla KK: COVID-19 transmission, current treatment, and future
therapeutic strategies. Mol Pharm. 18:754–771. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Morawska L and Cao J: Airborne
transmission of SARS-CoV-2: The world should face the reality.
Environ Int. 139(105730)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sahu KK, Mishra AK and Lal A: Trajectory
of the COVID-19 pandemic: Chasing a moving target. Ann Transl Med.
8(694)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Song F, Zhang X, Zha Y and Liu W:
COVID-19: Recommended sampling sites at different stages of the
disease. J Med Virol. 92:1383–1385. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lin C, Xiang J, Yan M, Li H, Huang S and
Shen C: Comparison of throat swabs and sputum specimens for viral
nucleic acid detection in 52 cases of novel coronavirus
(SARS-Cov-2)-infected pneumonia (COVID-19). Clin Chem Lab Med.
58:1089–1094. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Azzi L, Carcano G, Gianfagna F, Grossi P,
Gasperina DD, Genoni A, Fasano M, Sessa F, Tettamanti L, Carinci F,
et al: Saliva is a reliable tool to detect SARS-CoV-2. J Infect.
81:e45–e50. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Song C, Wang Y, Li W, Hu B, Chen G, Xia P,
Wang W, Li C, Diao F, Hu Z, et al: Absence of 2019 novel
coronavirus in semen and testes of COVID-19 patients. Biol Reprod.
103:4–6. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Di Mascio D, Khalil A, Saccone G, Rizzo G,
Buca D, Liberati M, Vecchiet J, Nappi L, Scambia G, Berghella V and
D'Antonio F: Outcome of Coronavirus spectrum infections (SARS,
MERS, COVID-19) during pregnancy: A systematic review and
meta-analysis. Am J Obstet Gynecol MFM. 2(100107)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
FDA-Important Information on the Use of
Serological (Antibody) Tests for COVID-19-Letter to Health Care
Providers. https://www.fda.gov/medical-devices/letters-health-care-providers/important-information-use-serological-antibody-tests-covid-19-letter-health-care-providers.
Accessed June 16, 2020.
|
|
44
|
CDC Interim Guidelines for COVID-19
Antibody Testing. 23 May. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html.
Accessed June 17, 2020.
|
|
45
|
CDC Using Antibody Tests for COVID-19, 28
May. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests.html.
Accessed June 17, 2020.
|
|
46
|
Ruan Q, Yang K, Wang W, Jiang L and Song
J: Clinical predictors of mortality due to COVID-19 based on an
analysis of data of 150 patients from Wuhan, China. Intensive Care
Med. 46:846–848. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Kluytmans M, Buiting A, Pas S, Bentvelsen
R, van den Bijllaardt W, van Oudheusden A, van Rijen M, Verweij J,
Koopmans M and Kluytmans J: SARS-CoV-2 infection in 86 healthcare
workers in two Dutch hospitals in March 2020. medRxiv: Mar 31, 2020
doi: 10.1101/2020.03.23.20041913.
|
|
48
|
Chen X, Tang Y, Mo Y, Li S, Lin D, Yang Z,
Yang Z, Sun H, Qiu J, Liao Y, et al: A diagnostic model for
coronavirus disease 2019 (COVID-19) based on radiological semantic
and clinical features: A multi-center study. Eur Radiol.
30:4893–4902. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yang P, Wang X, Liu P, Wei C, He B, Zheng
J and Zhao D: Clinical characteristics and risk assessment of
newborns born to mothers with COVID-19. J Clin Virol.
127(104356)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Liu D, Li L, Wu X, Zheng D, Wang J, Yang L
and Zheng C: Pregnancy and perinatal outcomes of women with
Coronavirus disease (COVID-19) Pneumonia: A preliminary analysis.
AJR Am J Roentgenol. 215:127–132. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Gupta N, Agrawal S, Ish P, Mishra S, Gaind
R, Usha G, Singh B and Sen MK: Safdarjung Hospital Covid Working
Group: Clinical and epidemiologic profile of the initial COVID-19
patients at a Tertiary Care Centre in India. Monaldi Arch Chest
Dis: Apr 10, 2020 (Epub ahead of print). doi:
10.4081/monaldi.2020.1294.
|
|
52
|
Kim GU, Kim MJ, Ra SH, Lee J, Bae S, Jung
J and Kim SH: Clinical characteristics of asymptomatic and
symptomatic patients with mild COVID-19 Clin Microbiol. Infect.
26:948.e1–948.e3. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Li R, Tian J, Yang F, Lv L, Yu J, Sun G,
Ma Y, Yang X and Ding J: Clinical characteristics of 225 patients
with COVID-19 in a tertiary Hospital near Wuhan, China J Clin.
Virol. 127(104363)2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Garg S, Kim L, Whitaker M, O'Halloran A,
Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, et
al: Hospitalization rates and characteristics of patients
hospitalized with laboratory-confirmed Coronavirus disease
2019-COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly
Rep. 69:458–464. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Shi X, Lu Y, Li R, Tang Y, Shi N, Song F,
Shan F, Chen G, Song P and Shi Y: Evaluation of antiviral therapies
for coronavirus disease 2019 pneumonia in Shanghai, China. J Med
Virol. 92:1922–1931. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu
W, Cheng Y, Yan J, Ping H and Zhou Q: Suspected myocardial injury
in patients with COVID-19: Evidence from front-line clinical
observation in Wuhan, China. Int J Cardiol. 311:116–121.
2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Du W, Yu J, Wang H, Zhang X, Zhang S, Li Q
and Zhang Z: Clinical characteristics of COVID-19 in children
compared with adults in Shandong Province, China. Infection.
48:445–452. 2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Hu L, Chen S, Fu Y, Gao Z, Long H, Wang
JM, Ren HW, Zuo Y, Li H, Wang J, et al: Risk factors associated
with clinical outcomes in 323 COVID-19 hospitalized patients in
Wuhan, China. Clin Infect Dis. 71:2089–2098. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
CDC COVID-19 Response Team.
Characteristics of health care personnel with COVID-19-United
States, February 12-April 9, 2020. MMWR Morb Mortal Wkly Rep.
69:477–481. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Colombi D, Bodini F, Petrini M, Maffi G,
Morelli N, Milanese G, Silva M, Sverzellati N and Michieletti E:
Well-aerated lung on admitting chest CT to predict adverse outcome
in COVID-19 Pneumonia. Radiology. 296:E86–E96. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Yang F, Shi S, Zhu J, Shi J, Dai K and
Chen X: Analysis of 92 deceased patients with COVID-19. J Med
Virol. 92:2511–2515. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Pedersen HP, Hildebrandt T, Poulsen A,
Uslu B, Knudsen HH, Roed J, Poulsen TD and Nielsen HB: Initial
experiences from patients with COVID-19 on ventilatory support in
Denmark. Dan Med J. 67(A04200232)2020.PubMed/NCBI
|
|
65
|
Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan
L, Cao J, Tan M, Xu W, Zheng F, et al: A tool to early predict
severe Corona Virus disease 2019 (COVID-19): A multicenter study
using the risk nomogram in Wuhan and Guangdong, China. Clin Infect
Dis. 71:833–840. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao
S, Long D and Yu L: Association between platelet parameters and
mortality in coronavirus disease 2019: Retrospective cohort study.
Platelets. 31:490–496. 2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Chen X, Zhao B, Qu Y, Chen Y, Xiong J,
Feng Y, Men D, Huang Q, Liu Y, Yang B, et al: Detectable serum
severe acute respiratory syndrome coronavirus 2 viral load
(RNAemia) is closely correlated with drastically elevated
interleukin 6 level in Critically Ill patients with coronavirus
disease 2019. Clin Infect Dis. 71:1937–1942. 2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Yu T, Cai S, Zheng Z, Cai X, Liu Y, Yin S,
Peng J and Xu X: Association between clinical manifestations and
prognosis in patients with COVID-19. Clin Ther. 42:964–972.
2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z
and Zhang Z: D-dimer levels on admission to predict in-hospital
mortality in patients with Covid-19. J Thromb Haemost.
18:1324–1329. 2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Borba MG, Val FF, Sampaio VS, Alexandre
MAA, Melo GC, Brito M, Mourão MPG, Brito-Sousa JD, Baía-da-Silva D,
Guerra MV, et al: Effect of high vs. low doses of chloroquine
diphosphate as adjunctive therapy for patients hospitalized with
severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)
infection: A randomized clinical trial. JAMA Netw Open.
3(e208857)2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Huang Y, Cai C, Zang J, Xie J, Xu D, Zheng
F, Zhan T, Huang K, Wang Y, Wang X, et al: Treatment strategies of
hospitalized patients with Coronavirus disease-19. Aging (Albany
NY). 12:11224–11237. 2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Lai CKC and Lam W: Laboratory testing for
the diagnosis of COVID-19. Biochem Biophys Res Commun. 538:226–230.
2021.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Chen Y, Klein SL, Garibaldi BT, Li H, Wu
C, Osevala NM, Li T, Margolick JB, Pawelec G and Leng SX: Aging in
COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev.
65(101205)2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Iftimie S, López-Azcona AF, Vallverdú I,
Hernández-Flix S, de Febrer G, Parra S, Hernández-Aguilera A, Riu
F, Joven J, Andreychuk N, et al: First and second waves of
coronavirus disease-19: A comparative study in hospitalized
patients in Reus, Spain. PLoS One. 16(e0248029)2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Contou D, Fraissé M, Pajot O, Tirolien JA,
Mentec H and Plantefève G: Comparison between first and second wave
among critically ill COVID-19 patients admitted to a French ICU: no
prognostic improvement during the second wave? Crit Care.
25(3)2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Taboada M, González M, Alvarez A, Eiras M,
Costa J, Álvarez J and Seoane-Pillado T: First, second and third
wave of COVID-19. What have we changed in the ICU management of
these patients? J Infect. 82:e14–e15. 2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Bager P, Wohlfahrt J, Rasmussen M,
Albertsen M and Krause TG: Hospitalisation associated with
SARS-CoV-2 delta variant in Denmark. Lancet Infect Dis.
21(1351)2021.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Shereen MA, Khan S, Kazmi A, Bashir N and
Siddique R: COVID-19 infection: Origin, transmission, and
characteristics of human coronaviruses. J Adv Res. 24:91–98.
2020.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Fan C, Li K, Ding Y, Lu WL and Wang J:
ACE2 expression in kidney and testis may cause kidney and testis
infection in COVID-19 patients. Front Med (Lausanne).
7(563893)2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Aaroe A, Majd N, Weathers SP and de Groot
J: Potential neurologic and oncologic implications of the novel
Coronavirus. Neuro Oncol. 22:1050–1051. 2020.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Xu P, Zhou Q and Xu J: Mechanism of
thrombocytopenia in COVID-19 patients. Ann Hematol. 99:1205–1208.
2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
He X, Lau EHY, Wu P, Deng X, Wang J, Hao
X, Lau YC, Wong JY, Guan Y, Tanet X, et al: Temporal dynamics in
viral shedding and transmissibility of COVID-19. Nat Med.
26:672–675. 2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Jiang F, Deng L, Zhang L, Cai Y, Cheung CW
and Xia Z: Review of the clinical characteristics of Coronavirus
Disease 2019 (COVID-19). J Gen Intern Med. 35:1545–1549.
2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Gao J, Zheng P, Jia Y, Chen H, Mao Y, Chen
S, Wang Y, Fu H and Dai J: Mental health problems and social media
exposure during COVID-19 outbreak. PLoS One.
15(e0231924)2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Lee S, Jobe M and Mathis A: Mental health
characteristics associated with dysfunctional coronavirus anxiety.
Psychol Med: Apr 16, 2020 (Epub ahead of print). doi:
10.1017/S003329172000121X.
|
|
86
|
Raptis CA, Hammer MM, Short RG, Shah A,
Bhalla S, Bierhals AJ, Filev PD, Hope MD, Jeudy J, Kligerman SJ and
Henry TS: Chest CT and Coronavirus Disease (COVID-19): A critical
review of the literature to date. AJR Am J Roentgenol. 215:839–842.
2020.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Rai P, Kumar BK, Deekshit VK and
Karunasagar I and Karunasagar I: Detection technologies and recent
developments in the diagnosis of COVID-19 infection. Appl Microbiol
Biotechnol. 105:441–455. 2021.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Yüce M, Filiztekin E and Özkaya KG:
COVID-19 diagnosis-A review of current methods. Biosens
Bioelectron. 172(112752)2021.PubMed/NCBI View Article : Google Scholar
|
|
89
|
NIH-Oxygenation and Ventilation. Available
from: https://www.covid19
treatmentguidelines.nih.gov/critical-care/oxygenation-and-ventilation/.
Accessed June 16, 2020.
|
|
90
|
Fu B, Xu X and Wei H: Why tocilizumab
could be an effective treatment for severe COVID-19? J Transl Med.
18(164)2020.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Regional Center for Poison Control and
Prevention-Chloroquine Toxicology Review. 25, 2003. http://www.maripoisoncenter.com/wp-content/uploads/2015/03/CTR-Chloroquine.pdf.
Accessed June 17, 2020.
|
|
92
|
Smit C, Peeters MY, van den Anker JN and
Knibbe CA: Chloroquine for SARS-CoV-2: Implications of its unique
pharmacokinetic and safety properties. Clin Pharmacokinet.
59:659–669. 2020.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Krumm ZA, Lloyd GM, Francis CP, Nasif LH,
Mitchell DA, Golde TE, Giasson BI and Xia Y: Precision therapeutic
targets for COVID-19. Virol J. 18(66)2021.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Hodgson SH, Mansatta K, Mallett G, Harris
V, Emary KR and Pollard AJ: What defines an efficacious COVID-19
vaccine? A review of the challenges assessing the clinical efficacy
of vaccines against SARS-CoV-2. Lancet Infect Dis. 21:e26–e35.
2021.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Soiza RL, Scicluna C and Thomson EC:
Efficacy and safety of COVID-19 vaccines in older people. Age
Ageing. 50:279–283. 2021.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Young B, Tan TT and Leo YS: The place for
remdesivir in COVID-19 treatment. Lancet Infect Dis. 21:20–21.
2021.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Hajissa K and Mussa A: Positive aspects of
the mRNA platform for SARS-CoV-2 vaccines. Hum Vaccin Immunother.
17:2445–2447. 2021.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Dai L and Gao GF: Viral targets for
vaccines against COVID-19. Nat Rev Immunol. 21:73–82.
2021.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Forni G and Mantovani A: COVID-19
Commission of Accademia Nazionale dei Lincei, Rome. COVID-19
vaccines: Where we stand and challenges ahead. Cell Death Differ.
28:626–639. 2021.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Baden LR, El Sahly HM, Essink B, Kotloff
K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB,
et al: Efficacy and safety of the Mrna-1273 SARS-CoV-2 vaccine. N
Engl J Med. 384:403–416. 2021.PubMed/NCBI View Article : Google Scholar
|
